Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 18, Issue 1, 2024 Jan, Article 102935 | Arvanitakis, Konstantinos; Koufakis, Theocharis; Kalopitas, Georgios;…AbstractBackground and aimsTreatment of type 2 diabetes (T2D) in patients with compensated cirrhosis is challenging due to hypoglycemic risk, altered pharmacokinetics, and the lack of robust evidence on the risk/benefit ratio of various drugs. Sub… Source

You may also like...